Wockhardt To Supply Coronavirus Vaccine To UK Government, Shares Soar 10%
Mumbai-based Wockhardt said on Monday it has entered into a fill-and-finish agreement with the UK government to supply COVID-19 vaccines. Fill-and-finish is the final manufacturing step of putting vaccines into vials or syringes and packaging them. In a regulatory filing during market hours, Wockhardt said it will manufacture the product at its Wrexham, North Wales-based subsidiary, CP Pharmaceuticals. Shares in Wockhardt surged to settle at Rs 303.40 apiece on the BSE, stuck in the upper circuit at 10 per cent, after the announcement. (Track Wockhardt Shares Here)
As part of the deal, Wockhardt said it has reserved the manufacturing capacity "to allow for the supply of multiple vaccines to the UK Government in its fight against COVID19, including AZD1222, the vaccine co-invented by the University of Oxford and its spinout company, Vaccitech and licensed by AstraZeneca".
“The pandemic of COVID-19 is a challenge for all and needs a concerted effort to overcome. We are proud to be collaborating with the UK Government to make vaccines available and the arrangement brings in a huge sense of purpose and pride, it upholds our ongoing commitment to fight against such a pandemic of global human importance," said Dr Habil Khorakiwala, founder chairman of Wockhardt.
"As a global organisation, we are focused and committed to assist in mitigating the worldwide impact of COVID-19,” he added.
Wockhardt said the UK government has reserved one fill-and-finish production line for its exclusive use over the next 18 months to guarantee the supply of vaccines required to fight COVID-19.
“Ensuring the UK has the capability to research, develop and manufacture a safe and effective vaccine is critical in our fight against coronavirus... Today we have secured additional capacity to manufacture millions of doses of multiple Covid-19 candidates, guaranteeing the supply of vaccines we need to protect people across the UK rapidly and in large numbers," said Alok Sharma, the UK government's secretary of state for business, energy and industrial strategy.
The Wockhardt stock sharply outperformed the benchmark S&P BSE Sensex benchmark index which extended losses to a fourth straight day amid a selloff in banking shares.
Wockhardt has been one of the largest suppliers for the UK's National Health Service (NHS) for more than 20 years.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.